250 related articles for article (PubMed ID: 35970627)
1. Interpretation, pitfalls of biomarkers in diagnosis of invasive fungal diseases.
Lass-Florl C; Alastruey-Izquierdo A; Gupta R; Chakroborti A
Indian J Med Microbiol; 2022; 40(4):480-484. PubMed ID: 35970627
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
3. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
[TBL] [Abstract][Full Text] [Related]
4. Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal Prophylaxis.
Fisher BT; Westling T; Boge CLK; Zaoutis TE; Dvorak CC; Nieder M; Zerr DM; Wingard JR; Villaluna D; Esbenshade AJ; Alexander S; Gunn S; Wheat LJ; Sung L
J Pediatric Infect Dis Soc; 2021 Sep; 10(8):864-871. PubMed ID: 34173659
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of invasive fungal diseases in pediatric patients.
Pana ZD; Vikelouda K; Roilides E
Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1203-1213. PubMed ID: 27681004
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic Value of G and GM Tests in Acute Leukemia Patients with Invasive Fungal Disease].
Qian KY; Lyu QX; Dai LJ; Chang HR; Wu DP; Sun AN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1678-1681. PubMed ID: 31607331
[TBL] [Abstract][Full Text] [Related]
7. Serology anno 2021-fungal infections: from invasive to chronic.
Lass-Flörl C; Samardzic E; Knoll M
Clin Microbiol Infect; 2021 Sep; 27(9):1230-1241. PubMed ID: 33601011
[TBL] [Abstract][Full Text] [Related]
8. Update on Non-Culture-Based Diagnostics for Invasive Fungal Disease.
Yan G; Chew KL; Chai LYA
Mycopathologia; 2021 Oct; 186(5):575-582. PubMed ID: 34213735
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of invasive fungal disease using serum (1→3)-β-D-glucan: a bivariate meta-analysis.
Lu Y; Chen YQ; Guo YL; Qin SM; Wu C; Wang K
Intern Med; 2011; 50(22):2783-91. PubMed ID: 22082890
[TBL] [Abstract][Full Text] [Related]
10. Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children.
Huppler AR; Fisher BT; Lehrnbecher T; Walsh TJ; Steinbach WJ
J Pediatric Infect Dis Soc; 2017 Sep; 6(suppl_1):S32-S44. PubMed ID: 28927202
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unit.
Talento AF; Dunne K; Joyce EA; Palmer M; Johnson E; White PL; Springer J; Loeffler J; Ryan T; Collins D; Rogers TR
J Crit Care; 2017 Aug; 40():119-127. PubMed ID: 28384600
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients.
Hammarström H; Stjärne Aspelund A; Christensson B; Heußel CP; Isaksson J; Kondori N; Larsson L; Markowicz P; Richter J; Wennerås C; Friman V
Mycoses; 2018 Sep; 61(9):623-632. PubMed ID: 29577474
[TBL] [Abstract][Full Text] [Related]
13. Prospective Evaluation of the Fungitell® (1→3) Beta-D-Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group.
Otto WR; Dvorak CC; Boge CLK; Ostrosky-Zeichner L; Esbenshade AJ; Nieder ML; Alexander S; Steinbach WJ; Dang H; Villaluna D; Chen L; Skeens M; Zaoutis TE; Sung L; Fisher BT
Pediatr Transplant; 2023 Feb; 27(1):e14399. PubMed ID: 36299233
[TBL] [Abstract][Full Text] [Related]
14. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
[TBL] [Abstract][Full Text] [Related]
16. Preemptive antifungal therapy: still a way to go.
Maertens J; Deeren D; Dierickx D; Theunissen K
Curr Opin Infect Dis; 2006 Dec; 19(6):551-6. PubMed ID: 17075330
[TBL] [Abstract][Full Text] [Related]
17. Serologic biomarkers in Candida and Aspergillus infections of the central nervous system: A comparison of galactomannan, mannan and β-1,3-D-gucan testing from serum and cerebrospinal fluid.
Forster J; Hoenigl M; Suerbaum S; Wagener J; Dichtl K
Mycoses; 2022 Jul; 65(7):709-714. PubMed ID: 35506957
[TBL] [Abstract][Full Text] [Related]
18. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).
Lortholary O; Fernández-Ruiz M; Perfect JR
J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of Fungal Infections. A Systematic Review and Meta-Analysis Supporting American Thoracic Society Practice Guideline.
Haydour Q; Hage CA; Carmona EM; Epelbaum O; Evans SE; Gabe LM; Knox KS; Kolls JK; Wengenack NL; Prokop LJ; Limper AH; Murad MH
Ann Am Thorac Soc; 2019 Sep; 16(9):1179-1188. PubMed ID: 31219341
[No Abstract] [Full Text] [Related]
20. Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease.
Acosta J; Catalan M; del Palacio-Pérez-Medel A; Montejo JC; De-La-Cruz-Bértolo J; Moragues MD; Pontón J; Finkelman MA; del Palacio A
Eur J Clin Microbiol Infect Dis; 2012 May; 31(5):721-31. PubMed ID: 21811868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]